World Leader in

Cell Expansion & Rejuvenation

What
We do

EnhanceTM
Platform

Proprietary hematopoietic stem cell (HSC) expansion and rejuvenation platform

Learn more

UM171 Cell
Therapy

Allogeneic stem cell therapy to treat blood cancers

Learn more

Pipeline

Pre-clinical pipeline for blood cancers and other diseases

Learn more

News

March 10, 2026

Zemcelpro® (dorocubicel) positive results in high- and very high-risk blood cancers to be reported at the EBMT 2026 Annual Meeting

– Zemcelpro® (dorocubicel) achieved remarkable and clinically meaningful survival results in patients with high- and very high-risk acute leukemias and myelodysplastic syndromes – Topline results from two Phase 2 studies to be presented on March 23, 2026 at the EBMT Annual Meeting in Madrid, Spain MONTREAL, March 10, 2026 – ExCellThera Inc. (ExCellThera), a world leader […]

Read more
See all articles

About us

Who we are

ExCellThera is an advanced clinical-stage company specializing in cell expansion and engineering, providing molecules and bioengineering solutions to expand and modify various cell lines for use in innovative single-use curative therapies for patients with hematological malignancies and other diseases.

Learn more
Symbol